These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33829606)

  • 21. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population.
    Wu Y; Jin M; Liu B; Liang X; Yu Y; Li Q; Ma X; Yao K; Chen K
    Mol Carcinog; 2011 Mar; 50(3):189-98. PubMed ID: 21104992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.
    Annuar AA; Ankathil R; Mohd Yunus N; Husin A; Ab Rajab NS; Abdul Aziz AA; Ibrahim MI; Sulong S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):565-571. PubMed ID: 33639675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: the association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib.
    Liu YC; Hsiao HH; Yang WC; Liu TC; Chang CS; Yang MY; Lin PM; Hsu JF; Lee CP; Lin SF
    Mol Carcinog; 2014 Dec; 53(12):951-9. PubMed ID: 23818300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
    Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
    Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between functional polymorphism of DNA repair genes (XRCC1, XPD) and clinical response in Indian chronic myeloid leukemia patients.
    Dhangar S; Shanbhag V; Shanmukhaiah C; Vundinti BR
    Mol Biol Rep; 2019 Oct; 46(5):4997-5003. PubMed ID: 31286393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.
    Guillem VM; Cervantes F; Martínez J; Alvarez-Larrán A; Collado M; Camós M; Sureda A; Maffioli M; Marugán I; Hernández-Boluda JC
    Am J Hematol; 2010 Jul; 85(7):482-6. PubMed ID: 20575039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms.
    Zhu Y; Yang H; Chen Q; Lin J; Grossman HB; Dinney CP; Wu X; Gu J
    DNA Repair (Amst); 2008 Feb; 7(2):141-8. PubMed ID: 17923445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
    Strom SS; Estey E; Outschoorn UM; Garcia-Manero G
    Leuk Lymphoma; 2010 Apr; 51(4):598-605. PubMed ID: 20141440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
    Jin B; Dong Y; Zhang X; Wang H; Han B
    PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XPC Lys939Gln polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians.
    Ahmad Aizat AA; Siti Nurfatimah MS; Aminudin MM; Ankathil R
    World J Gastroenterol; 2013 Jun; 19(23):3623-8. PubMed ID: 23801864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between three common genetic polymorphisms of XPC and susceptibility to heroin dependency.
    Qasemian-Talgard A; Saadat M
    Gene; 2020 Jan; 724():144153. PubMed ID: 31610221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.
    Malik SS; Zia A; Rashid S; Mubarik S; Masood N; Hussain M; Yasmin A; Bano R
    Breast Cancer; 2020 Nov; 27(6):1168-1176. PubMed ID: 32562189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeroderma pigmentosum genes and melanoma risk.
    Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
    Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
    Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between polymorphisms of Xeroderma pigmentosum complementation group C gene (XPC) and susceptibility to schizophrenia.
    Taghipour N; Saadat I; Saadat M
    Gene; 2019 May; 695():99-100. PubMed ID: 30769138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.
    Salimizand H; Amini S; Abdi M; Ghaderi B; Azadi NA
    Tumour Biol; 2016 Jan; 37(1):791-8. PubMed ID: 26250462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A 1:1 matched case-control study on the interaction between HBV, HCV infection and DNA repair gene XPC Ala499Val, Lys939Gln for primary hepatocellular carcinoma].
    Cai XL; Gao YH; Yu ZW; Wu ZQ; Zhou WP; Yang Y; Xu Y; Song SF; Chen SD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):942-5. PubMed ID: 20193233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in XPC gene and risk for prostate cancer.
    Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
    Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.